Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Medcomm
|
November 12, 2021
Bone marrow mesenchymal stem cell-conditioned medium facilitates fluid resolution via miR-214-activating epithelial sodium channels
Yan Ding, Yong Cui, Yapeng Hou, et al.
Biorxiv : the Preprint Server for Biology
|
January 14, 2021
Fibrinolysis influences SARS-CoV-2 infection in ciliated cells
Yapeng Hou, Yan Ding, Hongguang Nie, et al.
Frontiers in Medicine
|
September 26, 2025
Clinical features and recurrence risk prediction model in patients with idiopathic inflammatory myopathies-associated interstitial lung disease: a retrospective study from Ningbo
Di Wu, Yapeng Hou, Wei Fan, et al.
Journal of Ethnopharmacology
|
September 19, 2021
Luteolin attenuates lipopolysaccharide-induced acute lung injury/acute respiratory distress syndrome by activating alveolar epithelial sodium channels via cGMP/PI3K pathway
Yapeng Hou, Jun Li, Yan Ding, et al.
Current Drug Targets
|
May 5, 2020
Regulation of Cl- Electrolyte Permeability in Epithelia by Active Traditional Chinese Medicine Monomers for Diarrhea
Lei Chen, Yan Ding, Yapeng Hou, et al.
Fundamental & Clinical Pharmacology
|
June 6, 2022
MiR-199a-3p in mouse bone marrow mesenchymal stem cell exosomes increases epithelial sodium channel expression in lung injury
Lei Chen, Yapeng Hou, Danni Du, et al.
Current Pharmaceutical Design
|
September 2, 2020
Prospects for miR-21 as a Target in the Treatment of Lung Diseases
Yan Ding, Yapeng Hou, Yanhong Liu, et al.
Respiratory Research
|
December 14, 2020
Bone marrow mesenchymal stem cells derived miRNA-130b enhances epithelial sodium channel by targeting PTEN
Honglei Zhang, Yan Ding, Yapeng Hou, et al.
Biomed Research International
|
March 20, 2020
Lipopolysaccharide Inhibits Alpha Epithelial Sodium Channel Expression via MiR-124-5p in Alveolar Type 2 Epithelial Cells
Yan Ding, Yong Cui, Zhiyu Zhou, et al.
Current Pharmaceutical Design
|
July 7, 2022
Mesenchymal Stem Cell Therapy for ALI/ARDS: Therapeutic Potential and Challenges
Zhenxing Wang, Tong Yu, Yapeng Hou, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Medcomm
|
November 12, 2021
Bone marrow mesenchymal stem cell-conditioned medium facilitates fluid resolution via miR-214-activating epithelial sodium channels
Yan Ding, Yong Cui, Yapeng Hou, et al.
Biorxiv : the Preprint Server for Biology
|
January 14, 2021
Fibrinolysis influences SARS-CoV-2 infection in ciliated cells
Yapeng Hou, Yan Ding, Hongguang Nie, et al.
Frontiers in Medicine
|
September 26, 2025
Clinical features and recurrence risk prediction model in patients with idiopathic inflammatory myopathies-associated interstitial lung disease: a retrospective study from Ningbo
Di Wu, Yapeng Hou, Wei Fan, et al.
Journal of Ethnopharmacology
|
September 19, 2021
Luteolin attenuates lipopolysaccharide-induced acute lung injury/acute respiratory distress syndrome by activating alveolar epithelial sodium channels via cGMP/PI3K pathway
Yapeng Hou, Jun Li, Yan Ding, et al.
Current Drug Targets
|
May 5, 2020
Regulation of Cl- Electrolyte Permeability in Epithelia by Active Traditional Chinese Medicine Monomers for Diarrhea
Lei Chen, Yan Ding, Yapeng Hou, et al.
Fundamental & Clinical Pharmacology
|
June 6, 2022
MiR-199a-3p in mouse bone marrow mesenchymal stem cell exosomes increases epithelial sodium channel expression in lung injury
Lei Chen, Yapeng Hou, Danni Du, et al.
Current Pharmaceutical Design
|
September 2, 2020
Prospects for miR-21 as a Target in the Treatment of Lung Diseases
Yan Ding, Yapeng Hou, Yanhong Liu, et al.
Respiratory Research
|
December 14, 2020
Bone marrow mesenchymal stem cells derived miRNA-130b enhances epithelial sodium channel by targeting PTEN
Honglei Zhang, Yan Ding, Yapeng Hou, et al.
Biomed Research International
|
March 20, 2020
Lipopolysaccharide Inhibits Alpha Epithelial Sodium Channel Expression via MiR-124-5p in Alveolar Type 2 Epithelial Cells
Yan Ding, Yong Cui, Zhiyu Zhou, et al.
Current Pharmaceutical Design
|
July 7, 2022
Mesenchymal Stem Cell Therapy for ALI/ARDS: Therapeutic Potential and Challenges
Zhenxing Wang, Tong Yu, Yapeng Hou, et al.
Page
of 4